Concepedia

Correction to: Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)

Yuta Maruki, Chigusa Morizane, Yasuhito Arai, Masafumi Ikeda, Makoto Ueno, Tatsuya Ioka, Atsushi Naganuma, Masayuki Furukawa, Nobumasa Mizuno, Tadashi Uwagawa,

Journal of Gastroenterology · 2020 · 31 citations · 19 references

DOIFull text

Open access

Concepts

References

19

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Juan W. Valle, Harpreet Wasan, Daniel H. Palmer et al. · New England Journal of Medicine · 2010 · 4.4K citations · Full text

, , +12

Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

Ghassan K. Abou‐Alfa, Vaibhav Sahai, Antoine Hollebecque et al. · The Lancet Oncology · 2020 · 1.6K citations · Full text

, , +11

Genomic spectra of biliary tract cancer

Hiromi Nakamura, Yasuhito Arai, Yasushi Totoki et al. · Nature Genetics · 2015 · 1.3K citations

, , +14

Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

Ghassan K. Abou‐Alfa, Teresa Macarulla, Milind Javle et al. · The Lancet Oncology · 2020 · 1.1K citations · Full text

, , +8

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

Apinya Jusakul, Ioana Cutcutache, Chern Han Yong et al. · Cancer Discovery · 2017 · 989 citations · Full text

, , +17